Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Clinical trial NCT01280747 · TERMINATED
Trial details
- NCT number
- NCT01280747
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-04-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.